Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)
Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
Shandong Cancer Hospital and Institute
University Hospital, Strasbourg, France
University of Iowa
Blanco, Dr Antonio Calles MD
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Intergroupe Francophone de Cancerologie Thoracique
Ohio State University Comprehensive Cancer Center
University of Kentucky
Jeroen Bosch Ziekenhuis
University Hospital, Brest
Gruppo Oncologico Italiano di Ricerca Clinica
Centre hospitalier de l'Université de Montréal (CHUM)
University of Zurich
University of Leeds
Memorial Sloan Kettering Cancer Center
Lung Cancer Group Cologne
Samsung Medical Center
Hoosier Cancer Research Network
Massachusetts General Hospital
Ludwig Institute for Cancer Research
University of Nebraska
The Second Hospital of Shandong University
Zhejiang Cancer Hospital
Second Xiangya Hospital of Central South University
Fundación GECP
University of Louisville
Rigshospitalet, Denmark
University of Colorado, Denver
The Netherlands Cancer Institute
Massachusetts General Hospital
SCRI Development Innovations, LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Chonnam National University Hospital
Grupo de Investigación Clínica en Oncología Radioterapia
Emory University
Institut Bergonié
Samsung Medical Center
Samsung Medical Center
Intergroupe Francophone de Cancerologie Thoracique
The First Hospital of Jilin University
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Ankara City Hospital Bilkent
University of Colorado, Denver
University of Colorado, Denver